News in brief: AAMDC oncogene in aggressive breast cancer; Is it really MD care without PROs?; BMI may be good or bad for cancer survival

New breast cancer gene unravelled  A deep dive into the adipogenesis associated Mth938 domain containing (AAMDC) oncogene has revealed metabolic vulnerabilities that could be therapeutically exploited in aggressive ER-positive breast cancers. Research from the Harry Perkins Institute of Medical Research and the University of WA found AAMDC is overexpressed in high risk ER+ breast cancer ...

Already a member?

Login to keep reading.

© 2021 the limbic